Novartis grabs blockbuster cancer nod for Piqray on double good news day

28th May 2019 Uncategorised 0

Novartis’ promise of 25 potential blockbuster launches is steadily coming to fruition. On the same day the FDA approved gene therapy Zolgensma, the U.S. regulator also waved through breast cancer drug Piqray.

More: Novartis grabs blockbuster cancer nod for Piqray on double good news day
Source: fierce